These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 37744424)

  • 21. Increased Expression of
    Deng P; Zhou R; Zhang J; Cao L
    J Cancer; 2021; 12(11):3239-3248. PubMed ID: 33976733
    [No Abstract]   [Full Text] [Related]  

  • 22. Cyclic adenosine monophosphate/phosphodiesterase 4 pathway associated with immune infiltration and PD-L1 expression in lung adenocarcinoma cells.
    Tong L; Shan M; Zou W; Liu X; Felsher DW; Wang J
    Front Oncol; 2022; 12():904969. PubMed ID: 35978822
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pan-cancer analysis of UBE2T with a focus on prognostic and immunological roles in lung adenocarcinoma.
    Cao K; Ling X; Jiang X; Ma J; Zhu J
    Respir Res; 2022 Nov; 23(1):306. PubMed ID: 36357897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DPYSL2 as potential diagnostic and prognostic biomarker linked to immune infiltration in lung adenocarcinoma.
    Wu YJ; Nai AT; He GC; Xiao F; Li ZM; Tang SY; Liu YP; Ai XH
    World J Surg Oncol; 2021 Sep; 19(1):274. PubMed ID: 34517904
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inducible Co-Stimulator ICOS Expression Correlates with Immune Cell Infiltration and Can Predict Prognosis in Lung Adenocarcinoma.
    Wu G; He M; Ren K; Ma H; Xue Q
    Int J Gen Med; 2022; 15():3739-3751. PubMed ID: 35418779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FUT4 is involved in PD-1-related immunosuppression and leads to worse survival in patients with operable lung adenocarcinoma.
    Liu C; Li Z; Wang S; Fan Y; Zhang S; Yang X; Hou K; Tong J; Hu X; Shi X; Wang X; Liu Y; Che X; Qu X
    J Cancer Res Clin Oncol; 2019 Jan; 145(1):65-76. PubMed ID: 30357521
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pan-cancer landscape of CENPO and its underlying mechanism in LUAD.
    Shi T; Hu Z; Tian L; Yang Y
    Respir Res; 2023 Apr; 24(1):113. PubMed ID: 37061713
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heat shock factor 5 correlated with immune infiltration serves as a prognostic biomarker in lung adenocarcinoma.
    Aizemaiti R; Wu Z; Tang J; Yan H; Lv X
    Int J Med Sci; 2021; 18(2):448-458. PubMed ID: 33390814
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of Novel Prognostic Biomarkers Relevant to Immune Infiltration in Lung Adenocarcinoma.
    Xia Z; Rong X; Dai Z; Zhou D
    Front Genet; 2022; 13():863796. PubMed ID: 35571056
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of PTGES3 on the Prognosis and Immune Regulation in Lung Adenocarcinoma.
    Jiang W; Wei Q; Xie H; Wu D; He H; Lv X
    Anal Cell Pathol (Amst); 2023; 2023():4522045. PubMed ID: 37416927
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ZC3H12D is a prognostic biomarker associated with immune cell infiltration in lung adenocarcinoma.
    Gong W; Dai W; Wei H; Chen Y; Zheng Z
    Transl Cancer Res; 2020 Oct; 9(10):6128-6142. PubMed ID: 35117224
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Xu T; Xu S; Yao Y; Chen X; Zhang Q; Zhao X; Wang X; Zhu J; Liu N; Zhang J; Lin Y; Zou J
    J Thorac Dis; 2022 Feb; 14(2):515-535. PubMed ID: 35280459
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prediction of prognosis and immunotherapy response in lung adenocarcinoma based on CD79A, DKK1 and VEGFC.
    Zhang Q; Zhao M; Lin S; Han Q; Ye H; Peng F; Li L
    Heliyon; 2023 Aug; 9(8):e18503. PubMed ID: 37534013
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Predictive Role of Immune Related Subgroup Classification in Immune Checkpoint Blockade Therapy for Lung Adenocarcinoma.
    Yu X; Wang Z; Chen Y; Yin G; Liu J; Chen W; Zhu L; Xu W; Li X
    Front Genet; 2021; 12():771830. PubMed ID: 34721552
    [No Abstract]   [Full Text] [Related]  

  • 35. EZH2 as a prognostic-related biomarker in lung adenocarcinoma correlating with cell cycle and immune infiltrates.
    Fan K; Zhang BH; Han D; Sun YC
    BMC Bioinformatics; 2023 Apr; 24(1):149. PubMed ID: 37069494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TOX correlates with prognosis, immune infiltration, and T cells exhaustion in lung adenocarcinoma.
    Guo L; Li X; Liu R; Chen Y; Ren C; Du S
    Cancer Med; 2020 Sep; 9(18):6694-6709. PubMed ID: 32700817
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interferon Regulatory Factor 4 Correlated With Immune Cells Infiltration Could Predict Prognosis for Patients With Lung Adenocarcinoma.
    Li X; Zhai S; Zhang J; Zhang D; Wang S; Wang L; Yu J
    Front Oncol; 2021; 11():698465. PubMed ID: 34195096
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune-Related miRNA-195-5p Inhibits the Progression of Lung Adenocarcinoma by Targeting Polypyrimidine Tract-Binding Protein 1.
    Duan L; Wang J; Zhang D; Yuan Y; Tang L; Zhou Y; Jiang X
    Front Oncol; 2022; 12():862564. PubMed ID: 35600383
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GRAP2 is a prognostic biomarker and correlated with immune infiltration in lung adenocarcinoma.
    Song S; Deng X; Jiang S; Tian C; Han J; Chai J; Li N; Yan Y; Luo Z
    J Clin Lab Anal; 2022 Nov; 36(11):e24662. PubMed ID: 36181310
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of prognostic genes in the tumor microenvironment of lung adenocarcinoma.
    Xu ZY; Zhao M; Chen W; Li K; Qin F; Xiang WW; Sun Y; Wei J; Yuan LQ; Li SK; Lin SH
    PeerJ; 2020; 8():e9530. PubMed ID: 32775050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.